LOAMU
LJPC

Lombard Odier Asset Management (USA)’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-47,684
Closed -$1.32M – 227
2015
Q3 		$1.32M Buy
+47,684
New +$1.5M 0.12% 152

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s LJPC Position: Q4 2015 in Review

Lombard Odier Asset Management (USA) sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2015, closing a stake of 47,684 shares — an estimated $1.32M sold.

Lombard Odier Asset Management (USA) first reported a position in LJPC in Q3 2015 and held it in 1 quarter. The position peaked at $1.32M in Q3 2015. 80 funds tracked by Wall St. Rank hold LJPC as of Q4 2015.

  • Lombard Odier Asset Management (USA) reported no remaining La Jolla Pharmaceutical Company position as of Q4 2015 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 47,684 La Jolla Pharmaceutical Company shares in Q4 2015, an estimated $1.32M.
  • Lombard Odier Asset Management (USA) first reported a position in La Jolla Pharmaceutical Company in Q3 2015 and held it in 1 quarter.
  • Lombard Odier Asset Management (USA)'s La Jolla Pharmaceutical Company position peaked at $1.32M in Q3 2015.
  • 80 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2015.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2015, filed 16 Feb 2016.